Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.279. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
9.84 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NCI NIH HHS
Grant: T32 CA082084
NCI NIH HHS
Grant: UM1 CA186690
NIH HHS
Grant: S10 OD032141
NIH HHS
Grant: S10 OD028483
NCI NIH HHS
Grant: R50 CA211241
NCI NIH HHS
Grant: P30 CA047904
Fields of Study
Keywords
Sustainable Development Goals